Skip to main content

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Investor Securities Class Action Lawsuit 02/14/2017

  • If you purchased shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH), you may have certain options. Please contact the Shareholders Foundation Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 17, 2017 - The case was voluntarily dismissed. February 14, 2017 (Shareholders Foundation) - An investor in shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Anthera Pharmaceuticals Inc in connection with certain allegedly false and misleading...



You must register (for free) or login to view the entire case.